Chongqing Houjie Pharmaceutical Group Co., Ltd.

Chongqing Houjie Pharmaceutical Group Co., Ltd. was established in August 2017. It is a large-scale pharmaceutical industry enterprise built on the foundation of Chongqing Wanzhou District Pharmaceutical (Group) Co., Ltd. It is a mixed-ownership enterprise controlled by Chongqing Wanzhou Economic and Technological Development (Group) Co., Ltd. and an investor in the municipal key project, the Three Gorges International Health Industrial Park. It ranks among the top 100 pharmaceutical distribution enterprises in China. The company has over ten subsidiaries, including Chongqing Houjie Pharmaceutical Manufacturing Co., Ltd., Xingren Pharmaceutical Technology Chongqing Co., Ltd., and Chongqing Quanyu Cancer Hospital, covering multiple fields such as pharmaceutical trade, third-party logistics for drugs (devices), traditional Chinese medicine e-commerce, chain retail, pharmaceutical industry, medical device production, and tertiary cancer specialty hospitals (proton centers).
The company's predecessor was the Sichuan Province Wanxian City Pharmaceutical Procurement and Supply Station, founded in 1951 and restructured into a limited liability company in 2001. Through seventy years of development, the company has become an innovative, comprehensive, full-domain health and medical industry group with third-party logistics for drugs (devices) and pharmaceutical commerce as its main business, and traditional Chinese medicine industry and medical services as its two wings, with business throughout the country.
The Three Gorges International Health Industrial Park project covers an area of 500 mu, with a total investment of 3 billion yuan. The park has a total construction area of 410,000 square meters, with 23 above-ground buildings and 2 underground garages, including production plants, warehousing and logistics, cancer hospital, proton center, research building, and various supporting facilities. The park covers fields such as traditional Chinese medicine production, Chinese medicinal material processing, third-party logistics for drugs (devices), tertiary cancer hospital, and research centers. It is the most advanced health industry operation base in the northeastern Chongqing region.
Xingren Technology Company is the group's innovation business carrier. With the vision of "enabling every good traditional Chinese medicine practitioner to use good traditional Chinese medicines," it focuses on building a rigorously selected traditional Chinese medicine vertical e-commerce platform called "Yaocaicai." By integrating the traditional Chinese medicine decoction pieces industry chain, it innovates and upgrades the supply chain through a "two ends, one chain, one platform" approach, improves circulation efficiency, and provides one-stop traditional Chinese medicine decoction piece supply services with full variety, excellent quality, high cost-effectiveness, and good service to primary medical units such as clinics, health rooms, and pharmacies. Through independent research and development, Xingren Technology has obtained 16 software copyrights in the traditional Chinese medicine field, including "China Daodi Medicinal Materials Origin Management System V1.0," "Traditional Chinese Medicine Clinic Intelligent Management System V1.0," and "Traditional Chinese Medicine Decoction Pieces Circulation Big Data Monitoring System V1.0," initially establishing its core competitiveness in the industry.
The third-party drug (device) logistics center has a self-built drug warehouse area of 50,000 square meters, a professional pharmaceutical cold chain storage capacity of nearly 6,000 cubic meters, and more than 50 various delivery vehicles. The WMS modern intelligent warehousing management system it adopts integrates smart logistics systems, intelligent payment systems, and IoT management systems, and can meet the drug, medicinal material, and medical device storage and logistics distribution needs of pharmaceutical companies, medical and health service institutions, and pharmaceutical factories within Wanzhou District and a 500-kilometer radius. The warehouse can store over 300,000 pieces of drugs, with an annual turnover of approximately 1.5 million pieces and an annual circulation scale of approximately 7-10 billion yuan.
Chongqing Quanyu Cancer Hospital covers an area of 175 mu, with a total construction area of more than 240,000 square meters. It is a tertiary cancer specialty hospital. The hospital has multiple clinical and medical technology departments, including medical oncology, surgery, radiotherapy, minimally invasive intervention, and nuclear medicine. The total designed bed capacity of the cancer hospital is 1,700 beds. The hospital has a proton center and has introduced the advanced American Mevion Medical Systems compact proton radiotherapy system to provide patients with more precise and efficient medical services.
Chongqing Houjie Pharmaceutical Manufacturing Co., Ltd. covers an area of 150 mu, with a total construction area of 60,000 square meters. It has modern plants, inspection centers, etc., and possesses CNC automated production equipment and high-standard inspection equipment. The designed production capacity is 5,000 tons of traditional Chinese medicine decoction pieces and 3,000 tons of traditional Chinese medicine formula granules, and after reaching full production, the annual output value can reach more than 1 billion yuan. The pharmaceutical factory will build the region's most credible third-party testing center for drugs and food, promote the development and utilization of regional traditional Chinese medicinal material resources, and build a regional characteristic industry for traditional Chinese medicinal materials.
The company adheres to the corporate philosophy of "accumulating strength and taking the lead" and is committed to enabling every medical institution to use assured medicines, building a safe and convenient medical environment for all, and providing strong support for people's health and the prevention and control of public health emergencies.